BloombergLean L·
Roche Quarterly Sales Held Back by Blockbuster Eye Drug
Roche Holding’s results showed a slower-than-expected recovery for eye blockbuster Vabysmo as investors look to a key new drug to power growth ahead.
Read at Bloomberg →
Roche Holding’s results showed a slower-than-expected recovery for eye blockbuster Vabysmo as investors look to a key new drug to power growth ahead.
<iframe src="https://statesidedaily.com/embed/cluster/a26702c75c533590f07afe74b877742145aa220f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Roche Quarterly Sales Held Back by Blockbuster Eye Drug"></iframe>